​
​

Kinnate Biopharma Ownership | Who Owns Kinnate Biopharma?

OverviewForecastFinancialsChart

Kinnate Biopharma Ownership Summary

Kinnate Biopharma is owned by 73.45% institutional investors, and 26.55% retail investors. Yakira capital management is the largest institutional shareholder, holding 0% of KNTE shares. BlackRock Extended Mkt Composite is the top mutual fund, with 0.07% of its assets in Kinnate Biopharma shares.

KNTE Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockKinnate Biopharma73.45%-26.55%
SectorHealthcare Stocks 47.06%8.01%44.93%
IndustryBiotech Stocks 44.97%7.82%47.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Yakira capital management---
Renaissance---
Marshall wace, llp---
Trium capital llp---
Gsa capital partners llp---
Blackrock---
State board of administration of florida retirement system---
Tower research capital llc (trc)---
Foresite capital management iv---
Geode capital management---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Yakira capital management---
Renaissance---
Marshall wace, llp---
Trium capital llp---
Gsa capital partners llp---
Blackrock---
State board of administration of florida retirement system---
Tower research capital llc (trc)---
Foresite capital management iv---
Geode capital management---

Top Buyers

HolderShares% AssetsChange
Wells fargo & company/mn---144.00
Ubs group---818.00
Tower research capital llc (trc)---1.09K
Bank of america corp /de/---1.80K
Rhumbline advisers---2.93K

Top Sellers

HolderShares% AssetsChange
Foresite capital management iv---9.67M
Orbimed advisors---8.01M
Foresite capital management v---3.53M
Lynx1 capital management lp---1.98M
Viking global investors lp---1.82M

Sold Out

HolderChange
Wells fargo & company/mn-144.00
Ubs group-818.00
Tower research capital llc (trc)-1.09K
Bank of america corp /de/-1.80K
Rhumbline advisers-2.93K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202460-4.76%34,611,276-9.75%731.11%26-25.71%1935.71%
Dec 31, 2023638.62%38,350,735-0.59%811.19%3552.17%14-33.33%
Sep 30, 202358-20.55%38,578,905-3.69%821.06%23-43.90%21-8.70%
Jun 30, 202373-2.67%40,055,445-7.41%880.97%4136.67%234.55%
Mar 31, 202375-7.41%43,260,0985.97%951.11%30-9.09%22-15.38%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
BlackRock Extended Mkt Composite32.61K0.07%-
BlackRock Extended Equity Market K28.46K0.06%10.00
Vanguard Instl Ttl Stck Mkt Idx Tr15.09K0.03%-
NT Ext Equity Mkt Idx Fd - L13.46K0.03%-
Northern Trust Extended Eq Market Idx13.46K0.03%-
NT Ext Equity Mkt Idx Fd - NL12.96K0.03%-
NT Ext Equity Mkt Idx Fd - DC - NL - T210.42K0.02%6.00
Dimensional US Small Cap CIT Class S8.76K0.02%8.76K
BlackRock U.S. Equity Market F6.74K0.01%65.00
SSgA U.S. Extended Market Index Class I5.50K0.01%-

Recent Insider Transactions

DateNameRoleActivityValue
May 08, 2023Tananbaum James B. Buy$641.32K
May 08, 2023Tananbaum James B. Buy$4.34M
May 08, 2023Foresite Capital Management IV, LLC-Buy$4.34M
May 08, 2023Foresite Capital Management IV, LLC-Buy$641.32K
May 04, 2023ORBIMED ADVISORS LLC Buy$860.73K

Insider Transactions Trends

DateBuySell
2024 Q2--
2024 Q1--
2023 Q4--
2023 Q3--
2023 Q226-

KNTE Ownership FAQ

Who Owns Kinnate Biopharma?

Kinnate Biopharma shareholders are primarily institutional investors at 73.45%, followed by 0% insiders and 0% retail investors. The average institutional ownership in Kinnate Biopharma's industry, Biotech Stocks , is 44.97%, which Kinnate Biopharma exceeds.

Who owns the most shares of Kinnate Biopharma?

Kinnate Biopharma’s largest shareholders are Yakira capital management (0 shares, 0%), Renaissance (0 shares, 0%), and Marshall wace, llp (0 shares, 0%). Together, they hold 0% of Kinnate Biopharma’s total shares outstanding.

Does Blackrock own Kinnate Biopharma?

Yes, BlackRock owns 0% of Kinnate Biopharma, totaling 0 shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 0$. In the last quarter, BlackRock decreased its holdings by -431K shares, a -100.00% change.

Who is Kinnate Biopharma’s biggest shareholder by percentage of total assets invested?

Yakira capital management is Kinnate Biopharma’s biggest shareholder by percentage of total assets invested, with 0% of its assets in 0 Kinnate Biopharma shares, valued at 0$.

Who is the top mutual fund holder of Kinnate Biopharma shares?

BlackRock Extended Mkt Composite is the top mutual fund holder of Kinnate Biopharma shares, with 0.07% of its total shares outstanding invested in 32.61K Kinnate Biopharma shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools